Position in ABBV
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$24,887,950
+$2,301,397 QoQ
Shares Held
98,903
-4.8% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.62%
of 13F equity value
Holder Rank
#540
of 4,153 holders
Holding Since
Mar 2020
25 quarters on record
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PARK AVENUE SECURITIES LLC holds $165,157,657 across 14 Drug Manufacturers - General names. ABBV ranks #3 (15.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
35,602 | $42,702,110 | |
| 2 | JNJ |
Johnson & Johnson
|
119,431 | $30,331,891 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
98,903 | $24,887,950 | |
| 4 | MRK |
Merck & Co., Inc.
|
106,866 | $13,732,281 | |
| 5 | AZN |
Astrazeneca PLC
|
53,856 | $10,212,174 | |
| 6 | AMGN |
Amgen Inc
|
27,835 | $10,079,610 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
71,241 | $9,000,587 | |
| 8 | NVS |
Novartis AG
|
43,915 | $6,882,358 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24,887,950 | 98,903 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $22,586,553 | 103,851 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $24,776,313 | 108,435 | Shares | Sole | 2026-01-05 | |
| 2025-09-30 | $25,436,289 | 109,857 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $19,265,314 | 103,789 | Shares | Sole | 2025-07-14 | |
| 2024-12-31 | $15,577,892 | 87,664 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $13,682,401 | 69,285 | Shares | Sole | 2024-10-03 | |
| 2024-06-30 | $13,667,914 | 79,687 | Shares | Sole | 2024-07-09 | |
| 2024-03-31 | $14,182,676 | 77,884 | Shares | Sole | 2024-04-10 | |
| 2023-12-31 | $11,785,158 | 76,048 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $11,197,834 | 75,123 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $9,635,889 | 71,520 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $12,813,188 | 80,399 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $11,459,441 | 70,908 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $8,910,470 | 66,392 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $9,180,410 | 59,940 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $10,109,179 | 62,360 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $7,847,377 | 57,957 | Shares | Sole | 2022-04-08 | |
| 2021-09-30 | $5,652,172 | 52,398 | Shares | Sole | 2021-10-21 | |
| 2021-06-30 | $5,686,405 | 50,483 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $5,168,046 | 47,755 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $4,327,252 | 40,385 | Shares | Sole | 2021-01-20 | |
| 2020-09-30 | $3,172,159 | 36,216 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $3,436,692 | 35,004 | Shares | Sole | 2020-07-30 | |
| 2020-03-31 | $2,364,023 | 31,028 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||